ESC Premium Access

High level of growth differentiation factor 15 and lower left ventricular ejection fraction as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation

Congress Presentation

About the speaker

Doctor Alfira Belokurova

Tyumen Cardiology Research Center, Tyumen (Russian Federation)
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Hyogo, JP)


Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)


Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)


One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)


Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)


Access the full session

Atrial fibrillation e-posters

Speakers: Doctor A. Belokurova, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Following current guidelines, and beyond, Single-pill combinations (SPC) is a way to improve patient care in hypertension.

29 August 2021

Open Access

Patients with atrial fibrillation and comorbidities: what can we do in complex scenarios?

29 August 2021

Open Access

Classification of atrial fibrillation: what do the guidelines say?

29 August 2021

ESC 365 is supported by

logo Novo Nordisk